Donnatal

Product NDC
66213-422
11-digit product format
662130422
Labeler code
66213
Product ID
66213-422_fcbb3938-fca3-4ed6-96e4-446b7cdef5d6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
phenobarbital elixir
Dosage form
ELIXIR
Route
ORAL
Labeler
PBM Pharmaceuticals Inc.
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2011-07-01
Marketing end
0000-00-00
Substance
PHENOBARBITAL; HYOSCYAMINE SULFATE; SCOPOLAMINE HYDROBROMIDE; ATROPINE SULFATE
Active strength
16 mg/5mL; mg/5mL; mg/5mL; mg/5mL
Pharmacologic classes
Anticholinergic [EPC],Cholinergic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct66213-422IInactivated by FDA2026-10-05
excluded productproduct66213-422IInactivated by FDA2026-10-05
excluded packagepackage66213-42266213-422-04IInactivated by FDA2026-10-05
excluded packagepackage66213-42266213-422-16IInactivated by FDA2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 88 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage66213-422-04d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage66213-422-16d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage66213-422-04f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage66213-422-16f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage66213-422-042ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage66213-422-162ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage66213-422-04a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage66213-422-16a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage66213-422-04cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage66213-422-16cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage66213-422-04cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage66213-422-16cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage66213-422-04302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage66213-422-16302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage66213-422-04ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage66213-422-16ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage66213-422-040efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage66213-422-160efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage66213-422-04ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage66213-422-16ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage66213-422-04367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage66213-422-16367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage66213-422-04557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage66213-422-16557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproduct8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproduct8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage66213-422-048af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage66213-422-168af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproduct834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproduct834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage66213-422-04834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage66213-422-16834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage66213-422-041332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage66213-422-161332a3947898…d4bfe170f9cd…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c78bd43-efb4-4aeb-b7d8-eff1532f7822Product name420250801
41231c1e-8789-4da7-ac52-77fa90a85bf5Product name220250304
fe8ea78e-e1a4-44bf-a6b2-42eed76976bbProduct name520250218
e77ab9a2-80cf-4832-bff0-469bbc7cbcd0Product name220250214
5f84b7a7-523a-f042-dffb-1dadcd9b2407Product name420240110
e3e67a66-d325-4d80-8f9d-059e736d7b00Product name120230912
0cbc6fb2-78c0-4b88-98f0-a4cc76ff95caProduct name120230719
04cd5dc0-102f-46cb-8dbc-ca38dd2628d0Product name320230317
dfd25202-b8d2-4628-9213-f3e0f9eafce5Product name420210513
4199bf9b-4718-828a-6dd6-ac2fbbd61687Product name120140508
4edd8af5-cea7-ae42-8023-e91c5335db1dProduct name120140508
d3908afb-7784-440f-c406-88294732d36aProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
66213-422-042019-11-27C16284748780-19855e2a2-4a9a-60a7-e053-dbdaa90a05bdDonnatal Elixir Mint 4 oz
66213-422-162019-11-27C16284748780-19855e2a2-37b6-60a7-e053-dbdaa90a05bdDonnatal Elixir Mint 16 oz

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
66213-422-16Donnatal470 mL in 1 BOTTLEELIXIR4704
66213-422-04Donnatal118 mL in 1 BOTTLEELIXIR1183

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66213-422-04ML - Milliliter66213-422183dc367-8610-4b07-819c-7ff867d266f112012-07-24
66213-422-16ML - Milliliter66213-4225dda22b3-3cd0-42d0-ad80-85fb2bbe291d12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Atropine sulfateACTIVE INGREDIENT03J5ZE7KA5DONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
Hyoscyamine sulfateACTIVE INGREDIENTF2R8V82B84DONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
PhenobarbitalACTIVE INGREDIENTYQE403BP4DDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
Scopolamine hydrobromideACTIVE INGREDIENT451IFR0GXBDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
AtropineACTIVE MOIETY7C0697DR9IDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
HyoscyamineACTIVE MOIETYPX44XO846XDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
PhenobarbitalACTIVE MOIETYYQE403BP4DDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
ScopolamineACTIVE MOIETYDL48G20X8XDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
alcoholINACTIVE INGREDIENT3K9958V90MDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
FD&C Blue No. 1INACTIVE INGREDIENTH3R47K3TBDDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
FD&C Red No. 3INACTIVE INGREDIENTPN2ZH5LOQYDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
GlycerinINACTIVE INGREDIENTPDC6A3C0OXDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
MINTINACTIVE INGREDIENTFV98Z8GITPDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
saccharin sodiumINACTIVE INGREDIENTSB8ZUX40TYDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
sorbitolINACTIVE INGREDIENT506T60A25RDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
sucroseINACTIVE INGREDIENTC151H8M554DONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
waterINACTIVE INGREDIENT059QF0KO0RDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4
Atropine sulfateACTIVE INGREDIENT03J5ZE7KA5DONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
Hyoscyamine sulfateACTIVE INGREDIENTF2R8V82B84DONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
PhenobarbitalACTIVE INGREDIENTYQE403BP4DDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
Scopolamine hydrobromideACTIVE INGREDIENT451IFR0GXBDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
AtropineACTIVE MOIETY7C0697DR9IDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
HyoscyamineACTIVE MOIETYPX44XO846XDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
PhenobarbitalACTIVE MOIETYYQE403BP4DDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
ScopolamineACTIVE MOIETYDL48G20X8XDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
alcoholINACTIVE INGREDIENT3K9958V90MDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
FD&C Blue No. 1INACTIVE INGREDIENTH3R47K3TBDDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
FD&C Red No. 3INACTIVE INGREDIENTPN2ZH5LOQYDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
GlycerinINACTIVE INGREDIENTPDC6A3C0OXDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
MINTINACTIVE INGREDIENTFV98Z8GITPDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
saccharin sodiumINACTIVE INGREDIENTSB8ZUX40TYDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
sorbitolINACTIVE INGREDIENT506T60A25RDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
sucroseINACTIVE INGREDIENTC151H8M554DONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3
waterINACTIVE INGREDIENT059QF0KO0RDONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
66213-422DONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]4Legacy NDC, 1 package rows20131204_8d395651-e406-4448-98a7-fc6afc61282d.zip
66213-422DONNATAL (PHENOBARBITAL ELIXIR) ELIXIR [PBM PHARMACEUTICALS INC.]3Legacy NDC, 1 package rows20131204_ae03915e-8eca-4dab-94ac-00a4571b699b.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1046924Donnatal 16.2 MG / 0.1037 MG / 0.0194 MG / 0.0065 MG in 5 mL Oral SolutionPSN8d395651-e406-4448-98a7-fc6afc61282d4
1046787PHENobarbital 16.2 MG / hyoscyamine sulfate 0.1037 MG / atropine sulfate 0.0194 MG / scopolamine HBr 0.0065 MG in 5 mL Oral SolutionPSN8d395651-e406-4448-98a7-fc6afc61282d4
1046924atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Donnatal]SBD8d395651-e406-4448-98a7-fc6afc61282d4
1046787atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral SolutionSCD8d395651-e406-4448-98a7-fc6afc61282d4
1046787atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG per 5 ML Oral SolutionSY8d395651-e406-4448-98a7-fc6afc61282d4
1046924Donnatal (atropine sulfate 0.00388 MG / hyoscyamine sulfate 0.0207 MG / phenobarbital 3.24 MG / scopolamine hydrobromide 0.0013 MG) per ML Oral SolutionSY8d395651-e406-4448-98a7-fc6afc61282d4
1046924Donnatal (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG) per 5 ML Oral SolutionSY8d395651-e406-4448-98a7-fc6afc61282d4
1046924Donnatal (atropine sulfate 0.0388 MG / hyoscyamine sulfate 0.2074 MG / phenobarbital 32.4 MG / scopolamine hydrobromide 0.013 MG) per 10 ML Oral SolutionSY8d395651-e406-4448-98a7-fc6afc61282d4
1046924Donnatal 16.2 MG / 0.1037 MG / 0.0194 MG / 0.0065 MG in 5 mL Oral SolutionPSNae03915e-8eca-4dab-94ac-00a4571b699b3
1046787PHENobarbital 16.2 MG / hyoscyamine sulfate 0.1037 MG / atropine sulfate 0.0194 MG / scopolamine HBr 0.0065 MG in 5 mL Oral SolutionPSNae03915e-8eca-4dab-94ac-00a4571b699b3
1046924atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Donnatal]SBDae03915e-8eca-4dab-94ac-00a4571b699b3
1046787atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral SolutionSCDae03915e-8eca-4dab-94ac-00a4571b699b3
1046787atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG per 5 ML Oral SolutionSYae03915e-8eca-4dab-94ac-00a4571b699b3
1046924Donnatal (atropine sulfate 0.00388 MG / hyoscyamine sulfate 0.0207 MG / phenobarbital 3.24 MG / scopolamine hydrobromide 0.0013 MG) per ML Oral SolutionSYae03915e-8eca-4dab-94ac-00a4571b699b3
1046924Donnatal (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG) per 5 ML Oral SolutionSYae03915e-8eca-4dab-94ac-00a4571b699b3
1046924Donnatal (atropine sulfate 0.0388 MG / hyoscyamine sulfate 0.2074 MG / phenobarbital 32.4 MG / scopolamine hydrobromide 0.013 MG) per 10 ML Oral SolutionSYae03915e-8eca-4dab-94ac-00a4571b699b3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
66213-422-0466213042204118 mL in 1 BOTTLE118 mlHistorical
66213-422-1666213042216470 mL in 1 BOTTLE470 mlHistorical